ATE489367T1 - Verfahren und zwischenprodukt zur herstellung von donezepil - Google Patents

Verfahren und zwischenprodukt zur herstellung von donezepil

Info

Publication number
ATE489367T1
ATE489367T1 AT07700316T AT07700316T ATE489367T1 AT E489367 T1 ATE489367 T1 AT E489367T1 AT 07700316 T AT07700316 T AT 07700316T AT 07700316 T AT07700316 T AT 07700316T AT E489367 T1 ATE489367 T1 AT E489367T1
Authority
AT
Austria
Prior art keywords
donezepil
producing
intermediate product
relates
compounds
Prior art date
Application number
AT07700316T
Other languages
English (en)
Inventor
Srinivas Pathi
Vinod Acharya
Dharmaraj Rao
Rajendra Kankan
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Application granted granted Critical
Publication of ATE489367T1 publication Critical patent/ATE489367T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT07700316T 2006-01-04 2007-01-03 Verfahren und zwischenprodukt zur herstellung von donezepil ATE489367T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN17MU2006 2006-01-04
PCT/GB2007/000009 WO2007077443A1 (en) 2006-01-04 2007-01-03 Process and intermediate for preparation of donepezil

Publications (1)

Publication Number Publication Date
ATE489367T1 true ATE489367T1 (de) 2010-12-15

Family

ID=37728502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700316T ATE489367T1 (de) 2006-01-04 2007-01-03 Verfahren und zwischenprodukt zur herstellung von donezepil

Country Status (11)

Country Link
US (1) US8030491B2 (de)
EP (1) EP1973878B1 (de)
JP (1) JP2009524599A (de)
KR (1) KR20080085195A (de)
AT (1) ATE489367T1 (de)
AU (1) AU2007203969B2 (de)
CA (1) CA2635550A1 (de)
DE (1) DE602007010725D1 (de)
ES (1) ES2354737T3 (de)
NZ (1) NZ569532A (de)
WO (1) WO2007077443A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ569532A (en) 2006-01-04 2010-11-26 Cipla Ltd Process and intermediate for preparation of donepezil
WO2007108011A2 (en) * 2006-03-20 2007-09-27 Ind-Swift Laboratories Limited Process for the preparation of highly pure donepezil
US8247563B2 (en) 2006-12-11 2012-08-21 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
KR101062073B1 (ko) 2008-09-04 2011-09-02 주식회사종근당 도네페질, 염산도네페질 및 그의 중간체의 신규 제조방법
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
CN103524515B (zh) 2012-07-03 2016-07-06 浙江海正药业股份有限公司 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
PL197306B1 (pl) 1995-12-15 2008-03-31 Pfizer Nowe pochodne 4-[2-(3,4-dimetoksybenzoilo)allilo]piperydyny
IL125809A (en) 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US20050239837A1 (en) * 2002-08-14 2005-10-27 Gutman Arie L Process for production of highly pure donepezil hydrochloride
WO2004048326A1 (ja) * 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. 4−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
JP2004217639A (ja) * 2002-12-24 2004-08-05 Eisai Co Ltd アルツハイマー病治療剤
US6953856B2 (en) * 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
AU2003247158A1 (en) * 2003-07-01 2005-01-21 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
CN1300112C (zh) * 2004-01-06 2007-02-14 浙江大学 N-苄基-4-哌啶基甲醛的合成方法
WO2005076749A2 (en) * 2004-02-11 2005-08-25 Jubilant Organosys Limited A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine
NZ569532A (en) 2006-01-04 2010-11-26 Cipla Ltd Process and intermediate for preparation of donepezil

Also Published As

Publication number Publication date
US8030491B2 (en) 2011-10-04
AU2007203969A1 (en) 2007-07-12
JP2009524599A (ja) 2009-07-02
CA2635550A1 (en) 2007-07-12
KR20080085195A (ko) 2008-09-23
ES2354737T3 (es) 2011-03-17
EP1973878A1 (de) 2008-10-01
NZ569532A (en) 2010-11-26
US20090187020A1 (en) 2009-07-23
DE602007010725D1 (de) 2011-01-05
EP1973878B1 (de) 2010-11-24
AU2007203969B2 (en) 2012-04-05
WO2007077443A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
CY1123658T1 (el) Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
MY150596A (en) Hsp90 inhibitors
UA92083C2 (ru) Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом
WO2009090251A3 (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
ATE553083T1 (de) Verfahren zur herstellung eines 2- pyridylethylcarbonsäureamidderivats
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
MX2009004343A (es) Compuestos organicos.
MX2011005090A (es) Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)feni l] piperidina.
ATE489367T1 (de) Verfahren und zwischenprodukt zur herstellung von donezepil
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE483679T1 (de) Substituierte cyclohexylessigsäure-derivate
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE441627T1 (de) Verfahren zur herstellung von valsartan
EA200870038A1 (ru) Способ получения аминов
TW200635905A (en) Processes for producing 4-aminoquinazolines
MX2009005880A (es) Ciclohexenil-butenonas y composiciones de fragancia que las comprenden.
EP2604261A3 (de) SCCA-1-Produktionshemmer mit einem Carboxamidderivat und/oder einem Salz daraus als Wirkstoff
BRPI0516192A (pt) composto, e, método para a preparação de um composto
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
TW200736218A (en) Method for producing tertiary amines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties